Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience is a paper indexed in PICO Portal from OpenAlex.
How many citations does Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience have?
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience has 134 citations in the OpenAlex counts PICO Portal stores.
When was Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience published?
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience has 2016 year in the PICO Portal index.
What is the open-access status of Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience?
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience has bronze oa status in the PICO Portal index.
What is the DOI of Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience?
The DOI for Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience is on the source record.
What is the PMID of Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience?
The PMID for Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience is on the source record.
What is the OpenAlex record for Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience?
The OpenAlex for Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience is on the source record.